Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Alemtuzumab induction in renal transplantation.

Hanaway MJ, Woodle ES, Mulgaonkar S, Peddi VR, Kaufman DB, First MR, Croy R, Holman J; INTAC Study Group.

N Engl J Med. 2011 May 19;364(20):1909-19. doi: 10.1056/NEJMoa1009546.

2.

Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.

Hill P, Cross NB, Barnett AN, Palmer SC, Webster AC.

Cochrane Database Syst Rev. 2017 Jan 11;1:CD004759. doi: 10.1002/14651858.CD004759.pub2. Review.

PMID:
28073178
3.

Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.

Deeks ED, Keating GM.

Drugs. 2009 Jul 30;69(11):1483-512. doi: 10.2165/00003495-200969110-00007. Review.

PMID:
19634926
4.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

5.

Basiliximab: a review of its use as induction therapy in renal transplantation.

McKeage K, McCormack PL.

BioDrugs. 2010 Feb 1;24(1):55-76. doi: 10.2165/11203990-000000000-00000. Review.

PMID:
20055533
6.

Belatacept for kidney transplant recipients.

Masson P, Henderson L, Chapman JR, Craig JC, Webster AC.

Cochrane Database Syst Rev. 2014 Nov 24;(11):CD010699. doi: 10.1002/14651858.CD010699.pub2. Review.

PMID:
25416857
7.

Basiliximab: a review of its use as induction therapy in renal transplantation.

Chapman TM, Keating GM.

Drugs. 2003;63(24):2803-35. Review.

PMID:
14664658
8.

Rabbit antithymocyte globulin induction therapy in adult renal transplantation.

Hardinger KL.

Pharmacotherapy. 2006 Dec;26(12):1771-83. Review.

PMID:
17125438
9.

The efficacy and safety of alemtuzumab and daclizumab versus antithymocyte globulin during organ transplantation: a meta-analysis.

Hao WJ, Zong HT, Cui YS, Zhang Y.

Transplant Proc. 2012 Dec;44(10):2955-60. doi: 10.1016/j.transproceed.2012.05.085. Review.

PMID:
23195005
10.

Antibody induction therapy for lung transplant recipients.

Penninga L, Møller CH, Penninga EI, Iversen M, Gluud C, Steinbrüchel DA.

Cochrane Database Syst Rev. 2013 Nov 27;(11):CD008927. doi: 10.1002/14651858.CD008927.pub2. Review.

PMID:
24282128
11.

Alemtuzumab induction in renal transplantation: a meta-analysis and systemic review.

Zhang X, Huang H, Han S, Fu S, Wang L.

Transpl Immunol. 2012 Oct;27(2-3):63-8. doi: 10.1016/j.trim.2012.08.006. Epub 2012 Aug 30. Review.

PMID:
22960043
12.

Induction therapy in renal transplant recipients: how convincing is the current evidence?

Wagner SJ, Brennan DC.

Drugs. 2012 Mar 26;72(5):671-83. doi: 10.2165/11631300-000000000-00000. Review.

PMID:
22439670
13.

A benefit-risk assessment of basiliximab in renal transplantation.

Boggi U, Danesi R, Vistoli F, Del Chiaro M, Signori S, Marchetti P, Del Tacca M, Mosca F.

Drug Saf. 2004;27(2):91-106. Review.

PMID:
14717621
14.

Selection of induction therapy in kidney transplantation.

Hardinger KL, Brennan DC, Klein CL.

Transpl Int. 2013 Jul;26(7):662-72. doi: 10.1111/tri.12043. Epub 2012 Dec 31. Review.

15.

Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review.

Naesens M, Berger S, Biancone L, Crespo M, Djamali A, Hertig A, Öllinger R, Portolés J, Zuckermann A, Pascual J.

Nefrologia. 2016 Sep - Oct;36(5):469-480. doi: 10.1016/j.nefro.2016.03.019. Epub 2016 May 14. Review. English, Spanish.

16.

Steroid withdrawal in renal transplantation.

Grenda R.

Pediatr Nephrol. 2013 Nov;28(11):2107-12. doi: 10.1007/s00467-012-2391-6. Epub 2013 Jan 4. Review.

PMID:
23288351
17.
18.

Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?

Hellemans R, Bosmans JL, Abramowicz D.

Am J Transplant. 2017 Jan;17(1):22-27. doi: 10.1111/ajt.13884. Epub 2016 Jul 5. Review.

19.

Antithymocyte Globulin Induction Therapy in Liver Transplant: Old Drug, New Uses.

Petite SE, Bollinger JE, Eghtesad B.

Ann Pharmacother. 2016 Jul;50(7):592-8. doi: 10.1177/1060028016647974. Epub 2016 May 4. Review.

PMID:
27147705
20.

Basiliximab application on liver recipients: a meta-analysis of randomized controlled trials.

Zhang GQ, Zhang CS, Sun N, Lv W, Chen BM, Zhang JL.

Hepatobiliary Pancreat Dis Int. 2017 Apr;16(2):139-146. Review.

PMID:
28381376

Supplemental Content

Support Center